Bladder Cancer: Symptoms, Blood in Urine, Diagnosis and Treatment Options

Bladder cancer can develop without causing obvious symptoms in the early stages. When symptoms do occur, blood in the urine is the most common warning sign. It may be visible to the eye or detected only during a urine test. Blood in the urine does not automatically mean cancer. Urinary infection, kidney stones, bladder stones, prostate problems and other conditions can also cause it. The important point is that unexplained or recurrent blood in the urine should be properly evaluated rather than simply assumed to be an infection. Diagnosis may involve urine testing, imaging and cystoscopy. If a bladder tumour is found, transurethral resection of bladder tumour, or TURBT, is commonly used to remove the visible tumour and obtain tissue for pathology. Further treatment depends on whether the cancer is confined to the inner bladder layers or has invaded the bladder muscle.

Bladder cancer develops when abnormal cells in the lining or other tissues of the bladder grow in an uncontrolled way. The most common type is urothelial carcinoma.

Bladder cancer is often divided into non-muscle-invasive and muscle-invasive disease. This distinction is important because the depth of tumour invasion changes both the risk and the treatment approach.

Some bladder cancers remain confined to the inner layers of the bladder, while others grow into the bladder muscle or spread beyond it.

The most common symptom is blood in the urine, also called hematuria. The urine may look pink, red, rusty or dark, although the amount of blood can vary.

Blood may appear once and then disappear for some time. In other cases, it may recur. Small amounts of blood may not be visible at all and may only be detected during urine testing.

The absence of visible blood does not completely rule out a urinary problem, particularly when other symptoms or risk factors are present.

No. Blood in urine has many possible causes, and most people with hematuria do not automatically have bladder cancer.

Urinary tract infection, kidney stones, bladder stones, prostate conditions, urinary tract inflammation and other problems can all cause blood in urine.

However, unexplained blood in the urine should not simply be dismissed as an infection, particularly if it keeps returning, occurs without typical infection symptoms or appears in someone with important risk factors.

The risk of bladder cancer increases with age, and smoking is one of the most important preventable risk factors. Tobacco chemicals enter the bloodstream, are filtered by the kidneys and become concentrated in urine, exposing the bladder lining.

Certain workplace chemical exposures can also increase risk. These may be relevant to people who have long-term exposure to particular chemicals used in industries involving dyes, paints, metals, petroleum products and related materials.

Other risk factors include some previous cancer treatments, certain inherited conditions, chronic urinary problems and long-term catheter use in selected circumstances.

The evaluation starts with the symptoms, medical history and risk factors. A urine sample may be checked for blood, infection or abnormal cells.

Depending on the findings, the urologist may recommend imaging and cystoscopy. The choice of tests depends on the pattern of hematuria, symptoms, age, risk factors and previous test results.

If an abnormal area is seen inside the bladder, tissue may need to be removed and examined under a microscope to confirm whether cancer is present and determine its characteristics.

Cystoscopy is a procedure that allows the urologist to look directly inside the bladder and urethra using a thin camera called a cystoscope.

It is one of the key investigations when bladder cancer is suspected because it allows the doctor to see abnormal areas that may not be fully characterised by imaging alone.

If a suspicious lesion is found, tissue can be sampled or the patient may be scheduled for a procedure to remove the tumour and obtain a proper pathology specimen.

TURBT stands for transurethral resection of bladder tumour. It is performed by passing an instrument through the urethra into the bladder rather than making an external incision through the abdomen.

The visible bladder tumour is removed and the tissue is sent to a laboratory for pathological examination. The report helps determine the type, grade and depth of tumour invasion.

TURBT is an important part of the diagnosis and initial treatment of many non-muscle-invasive bladder cancers.

The pathology report provides information about the tumour cells and how deeply the cancer has invaded the bladder wall. It can also describe the tumour grade and other features that help determine recurrence and progression risk.

This information is important because two bladder tumours that look similar on an initial scan may require very different follow-up and treatment depending on their pathology.

Your urologist uses the pathology report along with the number and size of tumours, previous history and other findings to determine the next step.

Non-muscle-invasive bladder cancer has not grown into the muscle layer of the bladder. It includes several stages and risk groups, so it is not one single type of disease.

TURBT is commonly the initial treatment for these tumours. Depending on the risk of recurrence and progression, treatment may then include surveillance, intravesical chemotherapy or BCG therapy.

Regular follow-up cystoscopy is often an important part of care because bladder cancer can recur even after the visible tumour has been removed.

BCG, or bacillus Calmette-Guérin, is an immunotherapy that is placed directly into the bladder through a catheter. It is used for selected non-muscle-invasive bladder cancers, particularly cancers with a higher risk of recurrence or progression.

BCG is not the same as a routine antibiotic treatment. It is a form of intravesical immunotherapy designed to stimulate an immune response inside the bladder.

The number and schedule of BCG treatments depend on the tumour's risk category and the treatment plan recommended by the urology team.

When bladder cancer grows into the muscle layer, it is considered muscle-invasive bladder cancer. This changes the treatment approach because the risk of spread is higher.

Treatment may involve major surgery to remove the bladder, systemic chemotherapy before or after surgery, radiation-based treatment in selected situations, immunotherapy or other systemic treatments depending on the stage and individual circumstances.

The exact plan depends on the cancer stage, grade, overall health, kidney function and whether the cancer has spread.

Yes. Bladder cancer has several treatment options, and many cancers that are detected before they invade the bladder muscle can be treated without removing the bladder.

However, bladder cancer can recur, which is why follow-up is an important part of treatment. More advanced cancers require a different approach and may need a combination of surgery, chemotherapy, radiation, immunotherapy or other systemic treatments.

The outlook depends on the stage, grade, tumour characteristics, response to treatment and whether the cancer has spread.

There is no guaranteed way to prevent bladder cancer. However, avoiding tobacco is one of the most important steps a person can take to reduce risk.

People with relevant occupational exposures should follow workplace safety measures and use appropriate protective equipment.

There is no standard bladder cancer screening test recommended for people at average risk who have no symptoms. People with symptoms or significant risk factors should discuss appropriate evaluation with a doctor.

You should arrange a urology evaluation if you notice blood in your urine, particularly when there is no obvious explanation, or if blood keeps returning after an apparent urinary infection has been treated.

Persistent urinary symptoms, recurrent unexplained urinary problems or abnormal urine tests may also require further assessment.

Do not wait for severe pain. Bladder cancer does not always cause pain in its early stages, and blood in urine may be the first noticeable warning sign.

Blood in the urine is the most common symptom of bladder cancer, but it is not specific to cancer. Stones, infection, prostate problems and other urinary conditions can also cause hematuria.

If bladder cancer is suspected, cystoscopy is an important part of evaluation. When a tumour is found, TURBT can remove the visible tumour and provide tissue for pathology.

Treatment then depends on the tumour's stage, grade and risk category. Non-muscle-invasive cancers may be managed with TURBT, surveillance and intravesical treatment such as BCG, while muscle-invasive disease may require more extensive treatment.

The earlier an unexplained urinary symptom is properly evaluated, the sooner the actual cause can be identified and the appropriate treatment plan discussed.